Research
Micronutrients & recovery
Specific hypoglycemic agents, SGLT-2 inhibitors and GLP-1 receptor agonists, reduce cardiovascular event risk in patients with diabetes, particularly those with a history of CVD, independent of glycemic control levels.
If you have diabetes and a history of heart disease, ask your doctor about SGLT-2 inhibitors or GLP-1 receptor agonists, as they may offer heart protection benefits beyond just lowering blood sugar.
GoodSupportsMEDIUM confidence
The sodium glucose co-transporter 2 (SGLT-2) inhibitors and the glucagon-like peptide 1 (GLP-1) receptor agonists have been associated with reduced risk of CVD events among persons with diabetes, particularly for persons with a history of CVD.
Why this rating
Based on association with reduced risk in trials, though detailed review is beyond scope.
Source
Management of Cardiovascular Risk in Perimenopausal Women with Diabetes
Catherine Kim · Diabetes & Metabolism Journal · 2021
DOI 10.4093/dmj.2020.0262
narrative_reviewCited 18×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Estrogen therapy does not reduce cardiovascular disease events and may increase stroke risk in postmenopausal women, particularly those with diabetes, and is not recommended for chronic disease prevention.Strong
- Lifestyle behaviors (smoking cessation, weight reduction, physical activity, sodium restriction) are the core management strategy for cardiovascular risk in women with diabetes, despite limited randomized trial evidence for mortality reduction.Good
- Intensive blood pressure lowering to <130 mm Hg may be better tolerated and beneficial for perimenopausal women with diabetes compared to older populations, though standard guidelines recommend <140/90 mm Hg.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →